Emmanuel Profile picture
Oct 23 5 tweets 2 min read Read on X
IDENTIFYING HUNDREDS of POTENTIAL SUBTYPES of Long COVID from the electronic health records of over 12 million patients !!! 💯👍

nature.com/articles/s4174…Image
2) This study used a powerful data analysis technique called topic modeling to identify hundreds of potential sub-types of Long COVID.

The analysis revealed that PASC and COVID-19 patients experienced significantly higher rates of various conditions. Image
3) These spanned the nervous system (e.g. fatigue, headaches), cardiovascular system (e.g. heart rhythm issues), lungs (e.g. pneumonia), and immune system (e.g. autoimmune conditions). Image
4) Importantly, the study also found that certain Long COVID sub-types were more common in specific patient groups based on their age, sex, or the pandemic wave they were infected in. For example, pediatric and adolescent PASC patients showed increases in skin/hair problems. Image
5) Overall, this unprecedented analysis provides a detailed, data-driven look at the diverse ways Long COVID can manifest. It confirms many known symptoms, while also suggesting new avenues for better diagnosing and understanding this complex, multi-faceted condition.

Thanks 🙏 Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Emmanuel

Emmanuel Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ejustin46

Oct 25
HOW MUCH IMMUNITY the U.S. population had AGAINST SARS-COV-2 from 2020 to the end of 2023 ?

A key study 💯👍
medrxiv.org/content/10.110…Image
2) The researchers used a mathematical model to estimate this, using data on COVID-19 cases, hospitalizations, deaths, and vaccinations.

By the end of 2023, the model showed that almost everyone in the U.S. (99.9%) had been exposed to COVID-19 ... Image
3) ...either through infection or vaccination. However, despite this high level of exposure, only about half the population (53.6%) still had effective protection against getting infected again. The protection against severe illness was higher, at 82.6%. Image
Read 7 tweets
Oct 25
WHAT COULD HAPPEN with COVID-19?
(opinion)

It is both rare and commendable that someone like Arijit @arijitchakrav invests time in discussing the future risks associated with COVID-19 and SARS-CoV-2. In his recent thread, he presents two fascinating scenarios. Image
2) However, we believe that there could be a third scenario.
To explain this hypothesis we would like to take the example of cardiovascular diseases (CVD), which affect over 520 million people worldwide and are the leading cause of death, responsible for 32% of all fatalities..
3) ...and over 18 million deaths annually.
In the US, medical costs related to CVD surpass $200 billion each year, covering hospital stays, outpatient services, medications.
Furthermore, the economic burden from lost productivity is estimated at around $100 billion annually.
Read 12 tweets
Oct 24
If you SUFFER from PERSISTENT HEADACHES after a COVID-19 INFECTION,

... it may be due to elevated levels of the amyloid precursor protein (APP) in your blood
medrxiv.org/content/10.110…Image
2) This study looked at certain proteins in the blood of people with persistent headaches after COVID-19 infection. The main findings were:

- A protein called APP was much higher in people with headaches after COVID-19, and this was linked to problems with thinking and memory. Image
3) - Another protein called PZP was higher in the COVID-19 headache groups compared to healthy people.
- A third protein, CTSL, was only higher in the COVID-19 headache group at the start.
These results suggest changes ... Image
Read 4 tweets
Oct 24
"REPEATED COVID-19 mRNA-based VACCINATION CONTRIBUTES to SARS-CoV-2 NEUTRALIZING ANTIBODY RESPONSES in the MUCOSA"

Thanks to @DavidJoffe64 for the study
science.org/doi/10.1126/sc…Image
2) The study looked at how well COVID-19 vaccines, especially mRNA vaccines, can trigger immune responses in the nose and airways. The researchers found that getting multiple doses of the mRNA vaccines, especially booster shots ...
3) ...helped the body produce more virus-blocking antibodies in the nasal and respiratory secretions.

The antibodies in the blood and nose were connected - the antibodies made in the blood could also move into the nose and airways. Image
Read 9 tweets
Oct 23
10 to 15 TIMES MORE PEOPLE INFECTED compared to the REPORTED CASES COUNT !

An amazing study !!! 💯👍
medrxiv.org/content/10.110…Image
2) This study shows that the number of reported COVID-19 cases in the U.S. before the Omicron variant severely underestimated the true number of infections that were actually happening.
3) For example, in some states like New Jersey, Maryland, and Nevada, around 6-8% of infections were ever reported as cases. This means the real outbreak was much bigger than what the case numbers showed.

The researchers also found that infection outbreaks often started ... Image
Read 7 tweets
Oct 23
BEWARE of ABUSIVE SIMPLIFICATIONS !

SARS-CoV-2 has evolved a mechanism to circumvent an INNATE IMMUNE PATHWAY, it does not mean the virus completely defeats or disables the entire body's immune response ! Image
2) In the interesting study to which this article refers,

scientists found that the nucleocapsid protein, can be tagged by a special antiviral protein called ISG15. This tagging, called ISGylation, is done by an enzyme called HERC5. journals.asm.org/doi/10.1128/jv…Image
3) When the nucleocapsid protein is tagged by ISG15, it disrupts the way the protein normally assembles into larger structures, which the virus needs to replicate. This suggests ISGylation acts as a defense mechanism against the virus. Image
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(